Page 1 | Search Results | Blood | American Society of Hematology

1-12 of 12

Sort by

Sort Order Select

Journal Articles

Novel Small Molecule Inhibitors Of The Gas6/TAM Signaling Pathway Mediate Synergistic Inhibition Of Platelet Aggregation In Combination With ADP/P2Y Antagonists

Gilbert Acevedo, BS, Brian R. Branchford, MD, Luke Law, BS, Christine Brzezinski, Susan Sather, Gary Brodsky, PhD, Deborah DeRyckere, Ph.D., Weihe Zhang, H. Shelton Earp, III, Stephen V Frye, Douglas K. Graham, MD, PhD, Jorge Di Paola, MD

Blood (2013) 122 (21): 3507.

https://doi.org/10.1182/blood.V122.21.3507.3507

Published: 2013

Journal Articles

Novel Small Molecule Inhibitors Of The Gas6/TAM Signaling Pathway Inhibit Platelet Aggregation In Vitro and Protect Mice From Arterial and Venous Thrombosis In Vivo

Gilbert Acevedo, BS, Brian R. Branchford, MD, Christine Brzezinski, Susan Sather, Gary Brodsky, PhD, Deborah DeRyckere, Ph.D., Weihe Zhang, Jing Liu, H. Shelton Earp, III, Xiaodong Wang, Stephen V Frye, Douglas K. Graham, MD, PhD, Jorge Di Paola, MD

Blood (2013) 122 (21): 2296.

https://doi.org/10.1182/blood.V122.21.2296.2296

Published: 2013

Journal Articles

Development Of a Novel Small Molecule Inhibitor Of The Mer Tyrosine Kinase For Treatment Of Acute Lymphoblastic Leukemia

Deborah DeRyckere, Xiaodong Wang, Amanda A Hill, Weihe Zhang, Michael A Stashko, Susan Sather, Christopher E Cummings, William P Janzen, Stephen V Frye, H. Shelton Earp, III, Douglas K. Graham, MD, PhD

Blood (2013) 122 (21): 2666.

https://doi.org/10.1182/blood.V122.21.2666.2666

Published: 2013

Journal Articles

A Small Molecule Inhibitor of the Gas6/Mer Pathway Inhibits Platelet Activation and Thrombosis with Equal Efficacy to, but Greater Potency Than, iMer, the Novel MerTK Splice Variant

Brian R. Branchford, MD, Luke Law, BS, Susan Sather, BS, Gary Brodsky, PhD, H. Shelton Earp, III, Xiaodong Wang, Stephen Frye, Douglas K. Graham, MD, PhD, Jorge A Di Paola, MD

Blood (2012) 120 (21): 3303.

https://doi.org/10.1182/blood.V120.21.3303.3303

Published: 2012

Journal Articles

Evaluation of UNC569, a Novel Small Molecule Mer Inhibitor for the Treatment of ALL in Vitro and in Vivo.

Sandra Christoph, Deborah DeRyckere, PhD, Jennifer Schlegel, Susan Sather, BS, Amy McGranahan, J. Kimble Franzer, Alesia Trakhimets, Xiaodong Wang, Dmitri Kireev, William Janzen, Jing Liu, Chao Yang, Catherine Simpson, Jacqueline Norris-Drouin, Stephen Frye, H. Shelton Earp, III, Gary L. Johnson, Douglas K. Graham

Blood (2012) 120 (21): 2607.

https://doi.org/10.1182/blood.V120.21.2607.2607

Published: 2012

Journal Articles

UNC569 As Novel Small Molecule Mer Receptor Tyrosine Kinase Inhibitor for Treatment of ALL

Sandra Christoph, Deborah DeRyckere, PhD, Susan Sather, BS, Xiaodong Wang, Dmitri Kireev, William Janzen, Jing Liu, Chao Yang, Amy van Deusen, Catherine Simpson, Jacqueline Norris-Drouin, Stephen Frye, H. Shelton Earp, III, Gary L. Johnson, Douglas K. Graham

Blood (2011) 118 (21): 2589.

https://doi.org/10.1182/blood.V118.21.2589.2589

Published: 2011

Journal Articles

Imer Blocks Phosphorylation of the β 3 Integrin, Decreasing Platelet Activation Responses and Protecting Mice From Arterial Thrombosis

Brian R. Branchford, MD, Susan Sather, BS, Gary Brodsky, PhD, Tara C White-Adams, PhD, Deborah DeRyckere, Ph.D., Keith B Neeves, PhD, Katina M Wilson, BA, Steven R. Lentz, MD, PhD, Douglas K. Graham, MD, PhD, Jorge A Di Paola, MD

Blood (2011) 118 (21): 189.

https://doi.org/10.1182/blood.V118.21.189.189

Published: 2011

Journal Articles

Mer Receptor Tyrosine Kinase Is Over-Expressed In and Contributes to Oncogenesis In Acute Myeloid Leukemia

Alisa B. Lee-Sherick, MD, Kristen M. Eisenman, MD, Susan Sather, BS, Deborah DeRyckere, PhD, Jennifer Schlegel, Douglas K. Graham, MD, PhD

Blood (2011) 118 (21): 1390.

https://doi.org/10.1182/blood.V118.21.1390.1390

Published: 2011

Journal Articles

A soluble form of the Mer receptor tyrosine kinase inhibits macrophage clearance of apoptotic cells and platelet aggregation

Susan Sather, Karla D. Kenyon, Jerry B. Lefkowitz, Xiayuan Liang, Brian C. Varnum, Peter M. Henson, Douglas K. Graham

Blood (2006) 109 (3): 1026–1033.

https://doi.org/10.1182/blood-2006-05-021634

Published: 2006

Journal Articles

Lymphoblastic Leukemia/Lymphoma in Mice Overexpressing the Mer Receptor Tyrosine Kinase.

Dana B. Salzberg, MD, Amy K. Keating, MD, Adil Anwar, PhD, Kelly Sawczyn, MD, Kimberley Hill, Susan Sather, Jane Park, BS, Deborah DeRyckere, PhD, Doug Everett, PhD, Douglas K. Graham, MD, PhD

Blood (2005) 106 (11): 2619.

https://doi.org/10.1182/blood.V106.11.2619.2619

Published: 2005

Journal Articles

Ectopic Expression of Mer Receptor Tyrosine Kinase in Childhood T Cell Acute Lymphoblastic Leukemia.

Dana B. Salzberg, MD, Amy K. Keating, MD, Jian-zhe Cao, MA, Susan Sather, BS, Kimberley Hill, Adil Anwar, PhD, Douglas K. Graham, MD, PhD.

Blood (2004) 104 (11): 4310.

https://doi.org/10.1182/blood.V104.11.4310.4310

Published: 2004

Journal Articles

A Soluble Truncated Form of the Mer Tyrosine Kinase Inhibits Gas6 Activity in Platelets and Monocytes.

Douglas K. Graham, MD PhD, Susan Sather, BS

Blood (2004) 104 (11): 1561.

https://doi.org/10.1182/blood.V104.11.1561.1561

Published: 2004

NARROW

Novel Small Molecule Inhibitors Of The Gas6/TAM Signaling Pathway Mediate Synergistic Inhibition Of Platelet Aggregation In Combination With ADP/P2Y Antagonists

Novel Small Molecule Inhibitors Of The Gas6/TAM Signaling Pathway Inhibit Platelet Aggregation In Vitro and Protect Mice From Arterial and Venous Thrombosis In Vivo

Development Of a Novel Small Molecule Inhibitor Of The Mer Tyrosine Kinase For Treatment Of Acute Lymphoblastic Leukemia

A Small Molecule Inhibitor of the Gas6/Mer Pathway Inhibits Platelet Activation and Thrombosis with Equal Efficacy to, but Greater Potency Than, iMer, the Novel MerTK Splice Variant

Evaluation of UNC569, a Novel Small Molecule Mer Inhibitor for the Treatment of ALL in Vitro and in Vivo.

UNC569 As Novel Small Molecule Mer Receptor Tyrosine Kinase Inhibitor for Treatment of ALL

Imer Blocks Phosphorylation of the β 3 Integrin, Decreasing Platelet Activation Responses and Protecting Mice From Arterial Thrombosis

Mer Receptor Tyrosine Kinase Is Over-Expressed In and Contributes to Oncogenesis In Acute Myeloid Leukemia

A soluble form of the Mer receptor tyrosine kinase inhibits macrophage clearance of apoptotic cells and platelet aggregation

Lymphoblastic Leukemia/Lymphoma in Mice Overexpressing the Mer Receptor Tyrosine Kinase.

Ectopic Expression of Mer Receptor Tyrosine Kinase in Childhood T Cell Acute Lymphoblastic Leukemia.

A Soluble Truncated Form of the Mer Tyrosine Kinase Inhibits Gas6 Activity in Platelets and Monocytes.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only